Journey Medical (US:DERM) — Company Overview, News & Financial Data
Journey Medical focuses on developing prescription drugs for skin conditions, aiming to improve the dermatology care landscape.
Journey Medical
Journey Medical (NASDAQ:DERM) specializes in dermatology, focusing on acquiring, developing, and commercializing prescription drugs for skin conditions. The company's portfolio aims to address the needs of patients suffering from a variety of skin diseases, positioning Journey Medical to make a significant impact in the dermatology space. Their projects vary from research and development to the launch of innovative skincare solutions that seek to improve patients’ lives. Objective-wise, Journey Medical is dedicated to expanding its market presence through strategic partnerships, enhancing its product lineup, and pursuing growth opportunities to ensure they remain at the forefront of dermatology care.
Snapshot
Operations
Products and/or services of Journey Medical
- Acne Treatments: "Development and distribution of innovative prescription therapies for the management of acne conditions.
- Antifungal Solutions: Offers a range of topical treatments aimed at combating fungal skin infections.
- Dermatological Care Products: Produces dermatological products for a variety of skin conditions, enhancing skin health and appearance.
- Scarring and Wound Care: Provides advanced solutions for the treatment of scars and promotion of effective wound healing.
- Psoriasis Management: Delivers targeted treatments to alleviate the symptoms of psoriasis, improving patient quality of life.
- Dermatologic Surgical Devices: Markets surgical tools and devices designed specifically for dermatologic procedures, enhancing treatment efficiency and outcomes.
Journey Medical executive team
- Dr. Lindsay Allan Rosenwald M.D.Executive Chairman
- Mr. Claude MaraouiFounder, President, CEO & Director
- Mr. Joseph M. BeneschCFO & Corporate Controller
- Mr. Ramsey AlloushCOO, General Counsel & Company Secretary
- Mr. Robert NevinChief Commercial Officer
- Jaclyn JaffeSenior Director of Corporate Operations
- Mr. Louis DonatiDirector of Market Access